Cost-Minimization Analysis of Ranibizumab Versus Aflibercept for Treating Saudi Patients With Visual Impairment Owing to Age-Related Macular Degeneration or Diabetic Macular Edema

Autor: El-Dahiyat, Faris, Eljilany, Islam
Zdroj: In Value in Health Regional Issues September 2020 22:23-26
Databáze: ScienceDirect